|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/485 | (2006.01) |
| A61K 31/485 | (2013.01) | ||
| A61P 17/04 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 15/08 | (2018.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 15/08 | (2006.01) | ||
| A61P 17/04 | (2018.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 17/06 | (2018.01) | ||
| A61P 17/06 | (2006.01) | ||
| A61P 17/08 | (2018.01) | ||
| A61P 17/08 | (2006.01) | ||
| A61P 17/10 | (2018.01) | ||
| A61P 17/10 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/08 | (2018.01) | ||
| A61P 37/08 | (2006.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Number of the document | 2931279 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13863494.4 |
| Date of filing the European patent application | 2013-12-13 | |
| (97) | Date of publication of the European application | 2015-10-21 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/075096 |
| Date | 2013-12-13 |
| (87) | Number | WO 2014/093871 |
| Date | 2014-06-19 |
| (30) | Number | Date | Country code |
| 201261737488 P | 2012-12-14 | US | |
| 201213715625 | 2012-12-14 | US |
| (72) |
SCIASCIA, Thomas , US
|
| (73) |
Trevi Therapeutics, Inc. ,
195 Church Street
14th Floor, New Haven, Connecticut 06510,
US
|
| (54) | METHODS FOR TREATING PRURITUS |
| METHODS FOR TREATING PRURITUS |